|
|
||||||||
-Adrenergic and Cholinergic Mechanism
Department of Anesthesia, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27157-1009
Xu, Zemin, Chuanyao Tong, Hui-Lin Pan, Sergio E. Cerda, and James C. Eisenach. Intravenous morphine increases release of nitric oxide from spinal cord by an
-adrenergic and cholinergic mechanism. J. Neurophysiol. 78: 2072-2078, 1997. Systemic opioids produce analgesia in part by activating bulbospinal noradrenergic pathways. Spinally released norepinephrine (NE) has been suggested to produce analgesia in part by stimulating
2-adrenoceptors on cholinergic spinal interneurons to release acetylcholine (ACh). We hypothesized that this spinally released ACh would stimulate synthesis of nitric oxide (NO), and that spinally released NO after intravenous (IV) opioid injection thus would depend on a cascade of noradrenergic and cholinergic receptor stimulation. To test these hypotheses, IV morphine was administered to anesthetized sheep, and neurotransmitters in dorsal horn interstitial fluid were measured by microdialysis. IV morphine increased NE and ACh in dorsal horn microdialysates, and these increases were inhibited by IV naloxone or cervical spinal cord transection. IV morphine also increased dorsal horn microdialysate concentrations of nitrite, a stable metabolite of NO. Increases in NE, ACh, and nitrite were antagonized by prior intrathecal injection of the
2-adrenergic antagonist idazoxan, the muscarinic antagonist atropine, or the NO synthase inhibitor N-methyl-L-arginine (NMLA). To examine the concentration-dependent effects of spinal adrenergic stimulation, isolated rat spinal cord tissue was perfused with the
2-adrenergic agonist clonidine. Clonidine increased nitrite in the spinal cord tissue perfusate, an effect blocked by coadministration of idazoxan, atropine, and NMLA. These data support a previously hypothesized cascade of spinally released NE and ACh after systemic opioid administration. These data also suggest that spinally released NO plays a role in the analgesic effects of systemic opioids. In addition, these data imply a positive feedback whereby spinally released nitric oxide increases NE release and that has not previously been described.
This article has been cited by other articles:
![]() |
Y.-P. Chen, S.-R. Chen, and H.-L. Pan Systemic Morphine Inhibits Dorsal Horn Projection Neurons through Spinal Cholinergic System Independent of Descending Pathways J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li and J. C. Eisenach alpha 2A-Adrenoceptor Stimulation Reduces Capsaicin-Induced Glutamate Release from Spinal Cord Synaptosomes J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 939 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. U. Höglund, C. Hamilton, and L. Lindblom Effects of Microdialyzed Oxotremorine, Carbachol, Epibatidine, and Scopolamine on Intraspinal Release of Acetylcholine in the Rat J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 100 - 104. [Abstract] [Full Text] |
||||
![]() |
M. J. Garrido, M. Valle, M. A. Campanero, R. Calvo, and I. F. Trocóniz Modeling of the In Vivo Antinociceptive Interaction between an Opioid Agonist, (+)-O-Desmethyltramadol, and a Monoamine Reuptake Inhibitor, (-)-O-Desmethyltramadol, in Rats J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 352 - 359. [Abstract] [Full Text] |
||||
![]() |
X. Li, G. Rose, A. Chiari, H.-L. Pan, J. R. Tobin, and J. C. Eisenach 6-NO2-Norepinephrine Increases Norepinephrine Release and Inhibits Norepinephrine Uptake in Rat Spinal Synaptosomes J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 895 - 899. [Abstract] [Full Text] |
||||
![]() |
K. Taguchi, M. Kato, J. Kikuta, K. Abe, T. Chikuma, I. Utsunomiya, and T. Miyatake The Effects of Morphine-Induced Increases in Extracellular Acetylcholine Levels in the Rostral Ventrolateral Medulla of Rat J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1539 - 1544. [Abstract] [Full Text] |
||||
![]() |
F. T. KANEKO, A. C. ARROLIGA, R. A. DWEIK, S. A. COMHAIR, D. LASKOWSKI, R. OPPEDISANO, M. J. THOMASSEN, and S. C. ERZURUM Biochemical Reaction Products of Nitric Oxide as Quantitative Markers of Primary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 917 - 923. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |